Pharmaceuticals

HAINAN HAIYAO

HAINAN HAIYAO released FY2026 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 168.18 M, actual EPS CNY -0.0589

HAINAN HAIYAO FY2026 Q1 Earnings Release on April 28 After-Market (BJT)

HAINAN HAIYAO released FY2025 Q4 earnings on April 10 After-Market (BJT), actual revenue CNY 191.5 M, actual EPS CNY -0.1445

HAINAN HAIYAO released FY2025 earnings on April 10 After-Market BJT, actual revenue CNY 831.18 M, actual EPS CNY -0.3314

HAINAN HAIYAO FY2025 Earnings Release Scheduled for April 11 After-Market BJT

HAINAN HAIYAO released FY2025 9 Months Earnings on October 29 During-Market (BJT), actual revenue CNY 639.68 M, actual EPS CNY -0.1867

HAINAN HAIYAO released FY2025 Q3 earnings on October 29 During-Market (BJT), actual revenue CNY 189.41 M, actual EPS CNY -0.0648

HAINAN HAIYAO FY2025 Q3 Earnings Release on October 30 During-Market BJT

HAINAN HAIYAO released FY2025 Q2 earnings on August 26 During-Market (BJT), actual revenue CNY 243.68 M, actual EPS CNY -0.0692

HAINAN HAIYAO released FY2025 Semi-Annual earnings on August 26 During-Market (BJT), actual revenue CNY 450.27 M, actual EPS CNY -0.122

HAINAN HAIYAO to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)

Hainan Haiyao Expected to Report a Net Loss of 120 million to 160 million Yuan in the First Half of 2025

Haikou Pharmaceutical Factory Obtains Registration Certificate for Linezolid Tablets

Hainan Haiyao's Subsidiary's Cefoxitin Sodium for Injection Passes Consistency Evaluation

Rayliant Suggests Attention to Anti-Epilepsy Drugs Research Companies

Innovative drug concept stocks show significant gains

HAINAN HAIYAO released FY2025 Q1 earnings on April 29, 2025, After-Market BJT: Actual Revenue CNY 206.6 M, Actual EPS CNY -0.0527

HAINAN HAIYAO FY2025 Q1 Earnings Release Scheduled for April 30 After-Market BJT

HAINAN HAIYAO released FY2024 Q4 earnings on April 11 After-Market (BJT), actual revenue CNY 185.97 M, actual EPS CNY -0.9484

HAINAN HAIYAO released FY2024 earnings on April 11 After-Market (BJT), actual revenue CNY 990.7 M, actual EPS CNY -1.1756

300086

000566

002320

000572

000571

002163

The A-share Hainan Free Trade Zone concept fluctuated strongly, with SUNDIRO HOLDING hitting the daily limit, HNHD previously locked, and Caesar Travel, Honz, HNSS, HAINAN HAIYAO, and HAIMA AUTO following suit

Wallstreetcn

Honz

HNSS

HAIMA AUTO

SUNDIRO HOLDING

HNHD

300308

On November 26th at noon, the ChiNext Index rose by 2.76%, with CPO and pharmaceutical stocks collectively strengthening. The Shanghai Composite Index fluctuated narrowly, with Zhongji Innolight rising over 10%, reaching a historical high. Pharmaceutical stocks such as Huaren Health and HAINAN HAIYAO saw multiple stocks hitting the daily limit. The military industry sector adjusted, with Jiuzhiyang and Jianglong Shipbuilding falling over 10%. Nearly 3,000 stocks in the Shanghai, Shenzhen, and Beijing markets were in the green, with a morning trading volume of 1.14 trillion

Zhongji Innolight

November 26th Midday Review: The ChiNext Index rose 2.76% in half a day, with CPO and pharmaceutical stocks collectively strengthening

002474

002549

In the morning, the main funds had a net inflow into sectors such as media, agriculture, forestry, animal husbandry, and fishery, while there was a net outflow from sectors like non-ferrous metals, power equipment, and electronics. Specifically, in terms of individual stocks, RONGJI SOFTWARE, HAINAN HAIYAO, and KAIMEITE GASES saw net inflows of 1.377 billion yuan, 1.238 billion yuan, and 1.060 billion yuan, respectively. On the net outflow side, Zhongji Xuchuang, Aerospace Development, and Tianqi Lithium were sold off for 1.550 billion yuan, 1.251 billion yuan, and 1.179 billion yuan, respectively. (First Financial)

36Kr

RONGJI SOFTWARE

KAIMEITE GASES

In half a day, the main funds increased their positions in the media sector and sold off the non-ferrous metals sector

According to the Zhitong Finance APP, HAINAN HAIYAO announced that its wholly-owned subsidiary Haikou Pharmaceutical Factory Co., Ltd. recently obtained the "Drug Registration Certificate" for the chemical drug "Fumaric Acid Vonoprazan Tablets" issued by the National Medical Products Administration. The registration certificate states that the indication is: reflux esophagitis. It is used in combination with appropriate antibiotics to eradicate Helicobacter pylori

Zhitong

Hainan Haiyao's subsidiary has obtained the drug registration approval for Fumaric Acid Vorinostat Tablets

HAIAN HAIYAO announced that its revenue for the third quarter was 189 million yuan, a year-on-year decrease of 10.36%; the net profit loss was 84 million yuan. Revenue for the first three quarters was 640 million yuan, a year-on-year decrease of 20.51%; the net profit loss was 242 million yuan

HAIAN HAIYAO: Net loss of 84.002 million yuan in the third quarter

HAINAN HAIYAO stated on the interactive platform on October 28 that the company's product exports are mainly concentrated in Southeast Asia, and the company is actively developing the South American market, which is currently in the preliminary material declaration and approval stage. In the future, the company will continue to strengthen its efforts to expand into the markets of countries participating in the "Belt and Road" initiative and enhance its international operational capabilities

HAINAN HAIYAO: Actively developing the South American market, currently in the preliminary data submission and approval stage

HAINAN HAIYAO announced that some shares of the shareholder Southern Tongzheng, who holds more than 5% of the shares, are undergoing judicial auction. The Wuhan Intermediate People's Court will auction 130.8259 million shares pledged by Southern Tongzheng on JD.com, of which 98.11% are shares held by Southern Tongzheng, accounting for approximately 10.08% of the company's total share capital. The auction will be conducted in two rounds, with the second auction scheduled for November 1-2 and the first auction set for November 16-17. If the auction is successful, Southern Tongzheng's shareholding will be reduced to 0.19%. The company stated that this matter will not affect the controlling rights

HAIAN HAIYAO: There is new progress in the judicial auction of some shares held by shareholders with more than 5% ownership

000567

The Hainan Free Trade Zone sector fluctuated and rose, with HNSS hitting the daily limit and reaching a new high, while HAIMA AUTO, HAINAN HAIYAO, HDCM, Honz, and Caesar Travel also followed suit

HDCM

The Hainan Free Trade Zone sector fluctuated and rose, with HNSS hitting the limit up and reaching a new high

HAINAN HAIYAO announced that its shareholder, Southern Tongzheng, holding more than 5% of the shares, will conduct a judicial auction of 130,825,900 pledged shares, accounting for 98.11% of its holdings and 10.08% of the company's total share capital. Among them, 123,825,900 shares will be auctioned in the second round on October 15-16, 2025, and 7,000,000 shares will be auctioned in the first round on November 6-7, 2025. If the auction is successful, Southern Tongzheng's shareholding will decrease to 0.19%. The auction will not affect the company's control, and the outcome is still uncertain. The company will continue to disclose progress

HAINAN HAIYAO: Shares of shareholders holding more than 5% will be subject to judicial auction

On August 26th, HAINAN HAIYAO disclosed its semi-annual report, stating that the company achieved operating revenue of 450 million yuan in the first half of the year, a year-on-year decrease of 24.12%; the net loss attributable to shareholders of the listed company was 158 million yuan, compared to a loss of 200 million yuan in the same period last year; basic earnings per share were -0.122 yuan

HAIAN HAIYAO: Net loss attributable to the parent company in the first half of the year was 158 million yuan

HAINAN HAIYAO(000566.SZ)